Search

Search Constraints

You searched for: Author/Creator Hirt, Marc N.

Search Results

1. An Important Role for DNMT3A-Mediated DNA Methylation in Cardiomyocyte Metabolism and Contractility. Issue 16 (20th October 2020)

2. Deciphering the microRNA signature of pathological cardiac hypertrophy by engineered heart tissue- and sequencing-technology. (April 2015)

3. Front Cover: Toward Second‐Generation Cardiomyogenic and Anti‐cardiofibrotic 1, 4‐Dihydropyridine‐Class TGFβ Inhibitors (ChemMedChem 8/2019). (17th April 2019)

4. Glycoproteomics Reveals Decorin Peptides With Anti-Myostatin Activity in Human Atrial Fibrillation. Issue 11 (13th September 2016)

6. Hypertrophic signaling compensates for contractile and metabolic consequences of DNA methyltransferase 3A loss in human cardiomyocytes. (May 2021)

7. Pharmacological inhibition of DNA methylation attenuates pressure overload-induced cardiac hypertrophy in rats. (July 2018)

8. Recapitulation of dyssynchrony-associated contractile impairment in asymmetrically paced engineered heart tissue. (February 2022)

9. Toward Second‐Generation Cardiomyogenic and Anti‐cardiofibrotic 1, 4‐Dihydropyridine‐Class TGFβ Inhibitors. (28th February 2019)